Imunon Inc (IMNN)
1.40
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Imunon Research and Development Expense (Annual): 11.29M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.29M |
| December 31, 2022 | 11.73M |
| December 31, 2021 | 10.62M |
| December 31, 2020 | 11.34M |
| December 31, 2019 | 13.07M |
| December 31, 2018 | 11.87M |
| December 31, 2017 | 13.08M |
| December 31, 2016 | 14.62M |
| December 31, 2015 | 14.66M |
| December 31, 2014 | 14.97M |
| December 31, 2013 | 9.364M |
| December 31, 2012 | 15.77M |
| December 31, 2011 | 19.86M |
| December 31, 2010 | 14.71M |
| Date | Value |
|---|---|
| December 31, 2009 | 13.68M |
| December 31, 2008 | 12.01M |
| December 31, 2007 | 8.231M |
| December 31, 2006 | 9.345M |
| December 31, 2005 | 10.08M |
| December 31, 2004 | 11.53M |
| September 30, 2003 | 8.179M |
| September 30, 2002 | 5.005M |
| September 30, 2001 | 4.075M |
| September 30, 2000 | 2.238M |
| September 30, 1999 | 1.00M |
| September 30, 1998 | 1.535M |
| September 30, 1997 | 0.186M |
| September 30, 1996 | 0.094M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
10.62M
Minimum
2021
13.07M
Maximum
2019
11.61M
Average
11.34M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Avalo Therapeutics Inc | 13.78M |
| iBio Inc | 10.33M |
| Ocugen Inc | 39.57M |
| Petros Pharmaceuticals Inc | 2.409M |
| Moderna Inc | 4.845B |